• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?

作者信息

Bulut Gökten Dilara, Yümün Kavak Fatma, Mercan Rıdvan

机构信息

Department of Rheumatology, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdağ, Türkiye.

Deparment of Internal Medicine, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdağ, Türkiye.

出版信息

Arch Rheumatol. 2024 Mar 31;39(3):476-478. doi: 10.46497/ArchRheumatol.2024.10564. eCollection 2024 Sep.

DOI:10.46497/ArchRheumatol.2024.10564
PMID:39507836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11537692/
Abstract
摘要

相似文献

1
Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?利妥昔单抗会是狼疮所致难治性骨髓纤维化中的一线希望吗？
Arch Rheumatol. 2024 Mar 31;39(3):476-478. doi: 10.46497/ArchRheumatol.2024.10564. eCollection 2024 Sep.
2
Bone marrow involvement in systemic lupus erythematosus.系统性红斑狼疮的骨髓累及。
QJM. 2017 Nov 1;110(11):701-711. doi: 10.1093/qjmed/hcx102.
3
Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report.利妥昔单抗成功治疗难治性急性狼疮噬血细胞综合征：一例报告。
Mod Rheumatol Case Rep. 2020 Jul;4(2):222-228. doi: 10.1080/24725625.2019.1705529. Epub 2020 Jan 6.
4
Single-dose rituximab in refractory lupus nephritis.单剂量利妥昔单抗治疗难治性狼疮肾炎。
Intern Med J. 2016 Aug;46(8):899-901. doi: 10.1111/imj.13136.
5
The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis.利妥昔单抗联合贝利尤单抗或泰它西普治疗难治性狼疮性肾炎的疗效。
Rheumatology (Oxford). 2025 Jan 1;64(1):221-227. doi: 10.1093/rheumatology/kead674.
6
Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review.利妥昔单抗治疗难治性狼疮性肾炎患者的有效性和安全性分析：一项病历回顾研究
Clin Rheumatol. 2016 Feb;35(2):517-22. doi: 10.1007/s10067-015-3166-9. Epub 2016 Jan 14.
7
Refractory lupus panniculitis treated successfully with rituximab: Two cases.利妥昔单抗成功治疗难治性狼疮性脂膜炎：两例报告
Ann Afr Med. 2020 Jul-Sep;19(3):207-210. doi: 10.4103/aam.aam_42_19.
8
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.利妥昔单抗在对传统治疗难治的日本系统性红斑狼疮和狼疮性肾炎患者中的疗效和安全性。
Mod Rheumatol. 2016;26(1):80-6. doi: 10.3109/14397595.2015.1060665. Epub 2015 Aug 19.
9
Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.抗CD20抗体利妥昔单抗治疗难治性系统性红斑狼疮患者的疗效和安全性。
Lupus. 2018 Apr;27(5):802-811. doi: 10.1177/0961203317749047. Epub 2018 Jan 7.
10
Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.利妥昔单抗成功治疗与系统性红斑狼疮相关的难治性噬血细胞性淋巴组织细胞增生症和自身免疫性溶血性贫血。
Mod Rheumatol. 2014 Sep;24(5):855-7. doi: 10.3109/14397595.2013.874740. Epub 2014 Feb 11.

本文引用的文献

1
Reversible myelofibrosis secondary to systemic lupus erythematosus.系统性红斑狼疮所致可逆性骨髓纤维化。
BMJ Case Rep. 2023 Aug 17;16(8):e255229. doi: 10.1136/bcr-2023-255229.
2
Myelofibrosis associated with systemic lupus erythematosus successfully treated with rituximab.
Lupus. 2019 Nov;28(13):1612-1614. doi: 10.1177/0961203319879993. Epub 2019 Oct 10.
3
[Pancytopenia secondary to autoimmune myelofibrosis revealing a male case of systemic lupus].[自身免疫性骨髓纤维化继发全血细胞减少症，揭示一例男性系统性红斑狼疮病例]
Ann Biol Clin (Paris). 2019 Jun 1;77(3):327-330. doi: 10.1684/abc.2019.1443.
4
Systemic lupus erythematosus and myelofibrosis: A case report and revision of literature.系统性红斑狼疮与骨髓纤维化：一例病例报告及文献综述
Leuk Res Rep. 2018 Apr 10;9:58-64. doi: 10.1016/j.lrr.2018.04.004. eCollection 2018.
5
Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.骨髓作为系统性红斑狼疮的靶器官：骨髓纤维化病例分析
Int J Rheum Dis. 2018 May;21(5):1049-1059. doi: 10.1111/1756-185X.13308. Epub 2018 Apr 19.
6
A case of mistaken identity: When lupus masquerades as primary myelofibrosis.一例身份误诊：狼疮伪装成原发性骨髓纤维化。
SAGE Open Med Case Rep. 2013 Aug 20;1:2050313X13498709. doi: 10.1177/2050313X13498709. eCollection 2013.
7
Autoimmune myelofibrosis and systemic lupus erythematosus in a middle-aged male presenting only with severe anemia: a case report.一名仅表现为严重贫血的中年男性患者的自身免疫性骨髓纤维化和系统性红斑狼疮：病例报告
Medicine (Baltimore). 2015 May;94(19):e741. doi: 10.1097/MD.0000000000000741.
8
Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia.系统性红斑狼疮伴周围血细胞减少症的骨髓异常。
Clin Exp Rheumatol. 2012 Nov-Dec;30(6):825-9. Epub 2012 Dec 17.
9
B cell biomarkers of rituximab responses in systemic lupus erythematosus.系统性红斑狼疮中利妥昔单抗反应的B细胞生物标志物
Arthritis Rheum. 2011 Oct;63(10):3038-47. doi: 10.1002/art.30466.
10
Myelofibrosis in systemic lupus erythematosus: a new case.
Eur J Intern Med. 2000 Apr;11(2):98-100. doi: 10.1016/s0953-6205(00)00064-9.